Lipska K - Search Results

1

Diabetes and the WHO Model List of Essential Medicines.

Beran D, Besançon S, Ewen M, Gale EAM, Lazo-Porras M, Lepeska M, Lipska K, Zafra-Tanaka J, Zhaparova A, Yudkin JS. Beran D, et al. Among authors: lipska k. Lancet Diabetes Endocrinol. 2022 Jan;10(1):17-18. doi: 10.1016/S2213-8587(21)00323-5. Lancet Diabetes Endocrinol. 2022. PMID: 34919864 No abstract available.

2

Willingness to take less medication for type 2 diabetes among older patients: The Diabetes & Aging Study.

Haider S, Parker MM, Huang ES, Grant RW, Moffet HH, Laiteerapong N, Jain RK, Liu JY, Lipska KJ, Karter AJ. Haider S, et al. Among authors: lipska kj. J Am Geriatr Soc. 2024 Jul;72(7):1985-1994. doi: 10.1111/jgs.18870. Epub 2024 Mar 12. J Am Geriatr Soc. 2024. PMID: 38471959

3

Adjustment for Social Risk Factors in a Measure of Clinician Quality Assessing Acute Admissions for Patients With Multiple Chronic Conditions.

Lipska KJ, Altaf FK, Barthel AGB, Spatz ES, Lin Z, Herrin J, Bernheim SM, Drye EE. Lipska KJ, et al. JAMA Health Forum. 2023 Mar 3;4(3):e230081. doi: 10.1001/jamahealthforum.2023.0081. JAMA Health Forum. 2023. PMID: 36897581 Free article.

4

Development and Validation of the Life Expectancy Estimator for Older Adults with Diabetes (LEAD): the Diabetes and Aging Study.

Karter AJ, Parker MM, Moffet HH, Lipska KJ, Laiteerapong N, Grant RW, Lee C, Huang ES. Karter AJ, et al. J Gen Intern Med. 2023 Oct;38(13):2860-2869. doi: 10.1007/s11606-023-08219-y. Epub 2023 May 30. J Gen Intern Med. 2023. PMID: 37254010 Free PMC article.

5

Validation of a Hypoglycemia Risk Stratification Tool Using Data From Continuous Glucose Monitors.

Karter AJ, Parker MM, Moffet HH, Lipska KJ, Ralston JD, Huang ES, Gilliam LK. Karter AJ, et al. Among authors: lipska kj. JAMA Netw Open. 2023 Mar 1;6(3):e236315. doi: 10.1001/jamanetworkopen.2023.6315. JAMA Netw Open. 2023. PMID: 37000454 Free PMC article.

6

The idolatry of the surrogate.

Yudkin JS, Lipska KJ, Montori VM. Yudkin JS, et al. BMJ. 2011 Dec 28;343:d7995. doi: 10.1136/bmj.d7995. BMJ. 2011. PMID: 22205706 No abstract available.

7

ADDITION-Europe and the case for diabetes screening.

Yudkin JS, Montori VM, Lipska KJ, Gale EA. Yudkin JS, et al. Lancet. 2012 Jan 28;379(9813):313; author reply 313-4. doi: 10.1016/S0140-6736(12)60142-1. Lancet. 2012. PMID: 22284655 No abstract available.

8

Hard end points are needed for intensive glycaemic control in patients with type 2 diabetes.

Yudkin JS, Lipska KJ. Yudkin JS, et al. BMJ. 2012 Jan 31;344:e708; author reply e710. doi: 10.1136/bmj.e708. BMJ. 2012. PMID: 22293372 No abstract available.

9

WITHDRAWN: Promoting the use of DPP-4 inhibitors in Asia.

Lipska KJ, Beran D. Lipska KJ, et al. Diabetes Res Clin Pract. 2012 May 7:S0168-8227(12)00141-6. doi: 10.1016/j.diabres.2012.04.008. Online ahead of print. Diabetes Res Clin Pract. 2012. PMID: 22572104

10

Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010.

Lipska KJ, Ross JS, Van Houten HK, Beran D, Yudkin JS, Shah ND. Lipska KJ, et al. JAMA. 2014 Jun 11;311(22):2331-3. doi: 10.1001/jama.2014.6316. JAMA. 2014. PMID: 24915266 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

138 results

Search Page

Filters